Molecular mechanisms of resistance to first- and second-generation ALK inhibitors in ALK-rearranged lung cancer. (December 2016) - Gainor, J.; Dardaei, L.; Yoda, S.; Friboulet, L.; Leischler, I.; Katayama, R.; Dagogo-Jack, I.; Gadgeel, S.; Schultz, K.; Singh, M.; Chin, E.; Parks, M.; et al.